Using Reduced Inoculum Densities of<i> Mycobacterium tuberculosis</i> in MGIT Pyrazinamide Susceptibility Testing to Prevent False-Resistant Results and Improve Accuracy: A Multicenter Evaluation

<div>Procedural diagram of three MGIT PZA testing protocols.</div>

Tuberculosis Research and Treatment

fig1

Figure 1

Figure 1: Using Reduced Inoculum Densities of<i> Mycobacterium tuberculosis</i> in MGIT Pyrazinamide Susceptibility Testing to Prevent False-Resistant Results and Improve Accuracy: A Multicenter Evaluation 

Figure 1 | Using Reduced Inoculum Densities of Mycobacterium tuberculosis in MGIT Pyrazinamide Susceptibility Testing to Prevent False-Resistant Results and Improve Accuracy: A Multicenter Evaluation 